Abstract:BACKGROUND:Decades of efforts have attempted to differentiate the pluripotent stem cells (PSCs) into truly functional hematopoietic stem cells (HSCs), yet the problems of low differentiation efficiency in vitro and poor hematopoiesis reconstitution in vivo still exist, mainly attributing to the lack of solid, reproduced, or pursued differentiation system.METHODS:In this study, we established an in vitro differentiation system yielding in vivo hematopoietic reconstitution hematopoietic cells from mouse PSCs through a 3D induction system followed by coculture with OP9 stromal cells. The in vivo hematopoietic reconstitution potential of c-kit+ cells derived from the mouse PSCs was evaluated via m-NSG transplantation assay. Flow cytometry analysis, RNA-seq, and cell cycle analysis were used to detect the in vitro hematopoietic ability of endothelial protein C receptor (EPCR, CD201) cells generated in our induction system.RESULTS:The c-kit+ cells from 3D self-assembling peptide induction system followed by the OP9 coculture system possessed apparently superiority in terms of in vivo repopulating activity than that of 3D induction system followed by the 0.1% gelatin culture. We interestingly found that our 3D+OP9 system enriched a higher percentage of CD201+c-kit+cells that showed more similar HSC-like features such as transcriptome level and CFU formation ability than CD201-c-kit+cells, which have not been reported in the field of mouse PSCs hematopoietic differentiation. Moreover, CD201+ hematopoietic cells remained in a relatively slow cycling state, consistent with high expression levels of P57 and Ccng2. Further, we innovatively demonstrated that notch signaling pathway is responsible for in vitro CD201+ hematopoietic cell induction from mouse PSCs.CONCLUSIONS:Altogether, our findings lay a foundation for improving the efficiency of hematopoietic differentiation and generating in vivo functional HSC-like cells from mouse PSCs for clinical application.

Generation, expansion, and differentiation of cardiovascular progenitor cells from human pluripotent stem cells.

Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

Enhanced HSC-like Cell Generation from Mouse Pluripotent Stem Cells in a 3D Induction System Cocultured with Stromal Cells

Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Differentiation And Application Of Human Pluripotent Stem Cells Derived Cardiovascular Cells For Treatment Of Heart Diseases: Promises And Challenges

Scalable Cardiac Differentiation of Pluripotent Stem Cells Using Specific Growth Factors and Small Molecules

Expandable Cardiovascular Progenitor Cells Reprogrammed from Fibroblasts

Endothelial Progenitor Cells Produced From Human Pluripotent Stem Cells by a Synergistic Combination of Cytokines, Small Compounds, and Serum-Free Medium

Generation of expandable cardiovascular progenitor cells from mouse and human fibroblasts via direct chemical reprogramming

Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells

Generation of Clinical-Grade Functional Cardiomyocytes from Human Embryonic Stem Cells in Chemically Defined Conditions

Co‐Differentiation of Human Pluripotent Stem Cells‐Derived Cardiomyocytes and Endothelial Cells from Cardiac Mesoderm Provides a Three‐Dimensional Model of Cardiac Microtissue

Human Pluripotent Stem Cell-Derived Cardiovascular Cells: From Developmental Biology to Therapeutic Applications

Generation and characterization of cardiac valve endothelial-like cells from human pluripotent stem cells

Generation, Expansion and Functional Analysis of Endothelial Cells and Pericytes Derived from Human Pluripotent Stem Cells

Efficient Generation of Functional Cardiomyocytes from Human Umbilical Cord-Derived Virus-Free Induced Pluripotent Stem Cells

Guided Differentiation of Pluripotent Stem Cells for Cardiac Cell Diversity

Patient-specific Cardiovascular Progenitor Cells Derived from Integration-Free Induced Pluripotent Stem Cells for Vascular Tissue Regeneration

Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells